Similar articles

• [Fibrinolytic activity in Behçet's disease].

  Kogure M, Motoji K. Kogure M, et al. Nippon Ganka Gakkai Zasshi. 1972 Mar;76(3):114-21. Nippon Ganka Gakkai Zasshi. 1972. PMID: 4261805 Japanese. No abstract available.
• [Blood coagulation and fibrinolytic system in Behçet's disease (author's transl)].

  Hamada T, Hosoi Y, Yoshimura R, Yamamoto S. Hamada T, et al. Nihon Hifuka Gakkai Zasshi. 1978 Sep;88(10):615-25. Nihon Hifuka Gakkai Zasshi. 1978. PMID: 309522 Japanese. No abstract available.
• Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.

  Kluft C, Michiels JJ, Wijngaards G. Kluft C, et al. Scand J Haematol. 1980 Nov;25(5):423-30. doi: 10.1111/j.1600-0609.1981.tb01424.x. Scand J Haematol. 1980. PMID: 6452679
• [The fibrinolytic system. Endogenous and exogenous activation in the drug treatment of thrombosis].

  Meneghini P, Giuron G, Gallo L, Lo Pinto G, Claudiani F. Meneghini P, et al. Recenti Prog Med. 1982 Jun;72(6):770-800. Recenti Prog Med. 1982. PMID: 6216564 Review. Italian. No abstract available.
• Behçet's disease and thrombophilia.

  Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M. Leiba M, et al. Ann Rheum Dis. 2001 Dec;60(12):1081-5. doi: 10.1136/ard.60.12.1081. Ann Rheum Dis. 2001. PMID: 11709446 Free PMC article. Review. No abstract available.